Your browser doesn't support javascript.
loading
The Burden of Uncontrolled Cardiovascular Risk Factors in Men With Prostate Cancer: A RADICAL-PC Analysis.
Klimis, Harry; Pinthus, Jehonathan H; Aghel, Nazanin; Duceppe, Emmanuelle; Fradet, Vincent; Brown, Ian; Siemens, D Robert; Shayegan, Bobby; Klotz, Laurence; Luke, Patrick P; Niazi, Tamim; Lavallee, Luke T; Mousavi, Negareh; Hamilton, Robert J; Chin, Joseph L; Gopaul, Darin; Violette, Philippe D; Davis, Margot K; Hanna, Nawar; Sabbagh, Robert; Ben Zadok, Osnat Itzhaki; Hajjar, Ludhmila Abrahão; Kann, Ariel Galapo; Mian, Rajibul; Rangarajan, Sumathy; Huei Ng, Kelvin Kuan; Iakobishvili, Zaza; Selvanayagam, Joseph B; Avezum, Alvaro; Leong, Darryl P.
Affiliation
  • Klimis H; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Pinthus JH; Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
  • Aghel N; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Duceppe E; Department of Medicine, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Fradet V; Department of Medicine, University of Montreal, Montreal, Quebec, Canada.
  • Brown I; Department of Surgery, Université Laval, Quebec, Canada.
  • Siemens DR; Research Center of CHU de Québec, Université Laval, Oncology Axis, Quebec, Canada.
  • Shayegan B; CHU de Québec, Site L'Hôtel-Dieu de Québec, Quebec, Canada.
  • Klotz L; Division of Urology, Niagara Health System, Saint Catharines, Ontario, Canada.
  • Luke PP; Queen's Cancer Research Institute, Kingston, Ontario, Canada.
  • Niazi T; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
  • Lavallee LT; Department of Urology, Queen's University, Kingston, Ontario, Canada.
  • Mousavi N; Department of Surgery, Division of Urology, St Joseph's Healthcare, McMaster University, Hamilton, ON, Canada.
  • Hamilton RJ; Department of Surgery, Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Chin JL; Department of Surgery, Division of Urology, London Health Sciences Centre, Western University, London, Ontario, Canada.
  • Gopaul D; Radiation Oncology Department, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
  • Violette PD; Division of Urology, Department of Surgery, The Ottawa Hospital, The University of Ottawa, Ottawa, Ontario, Canada.
  • Davis MK; Department of Medicine, Division of Cardiology, McGill University Health Center, Montreal, Quebec, Canada.
  • Hanna N; Department of Surgery, Division of Urology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Sabbagh R; Department of Urology, University of Western Ontario, London Health Sciences Centre, London, Ontario, Canada.
  • Ben Zadok OI; Department of Medicine, Division of Radiation Oncology, Grand River Regional Cancer Centre, Kitchener, Ontario, Canada.
  • Hajjar LA; Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
  • Kann AG; Woodstock Hospital, Woodstock, Ontario, Canada.
  • Mian R; Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Rangarajan S; Department of Surgery, Division of Urology, CIUSSS de l'Est-de-l'Île-de-Montréal, Installation Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada.
  • Huei Ng KK; Department of Surgery, Division of Urology, Université de Sherbrooke, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada.
  • Iakobishvili Z; Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel.
  • Selvanayagam JB; Department of Cardiology, Instituto do Coração, Universidade de São Paulo, São Paulo, Brazil.
  • Avezum A; Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
  • Leong DP; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
JACC CardioOncol ; 5(1): 70-81, 2023 Feb.
Article in En | MEDLINE | ID: mdl-36875906
ABSTRACT

Background:

Cardiovascular disease (CVD) incidence is higher in men with prostate cancer (PC) than without.

Objectives:

We describe the rate and correlates of poor cardiovascular risk factor control among men with PC.

Methods:

We prospectively characterized 2,811 consecutive men (mean age 68 ± 8 years) with PC from 24 sites in Canada, Israel, Brazil, and Australia. We defined poor overall risk factor control as ≥3 of the following suboptimal low-density lipoprotein cholesterol (>2 mmol/L if Framingham Risk Score [FRS] ≥15 and ≥3.5 mmol/L if FRS <15), current smoker, physical inactivity (<600 MET min/wk), suboptimal blood pressure (BP) (≥140/90 mm Hg if no other risk factors, systolic BP ≥120 mm Hg if known CVD or FRS ≥15, and ≥130/80 mm Hg if diabetic), and waisthip ratio >0.9.

Results:

Among participants (9% with metastatic PC and 23% with pre-existing CVD), 99% had ≥1 uncontrolled cardiovascular risk factor, and 51% had poor overall risk factor control. Not taking a statin (odds ratio [OR] 2.55; 95% CI 2.00-3.26), physical frailty (OR 2.37; 95% CI 1.51-3.71), need for BP drugs (OR 2.36; 95% CI 1.84-3.03), and age (OR per 10-year increase 1.34; 95% CI 1.14-1.59) were associated with poor overall risk factor control after adjustment for education, PC characteristics, androgen deprivation therapy, depression, and Eastern Cooperative Oncology Group functional status.

Conclusions:

Poor control of modifiable cardiovascular risk factors is common in men with PC, highlighting the large gap in care and the need for improved interventions to optimize cardiovascular risk management in this population.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: JACC CardioOncol Year: 2023 Document type: Article Affiliation country: Canadá

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: JACC CardioOncol Year: 2023 Document type: Article Affiliation country: Canadá
...